SLXNW Silexion Therapeutics Corp.

Fundamentals / CIK 0002022416 / USD
Other share classes on CIK 0002022416: SLXN

Silexion Therapeutics Corp. reported $6.83M in total assets and a net loss of $13.23M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SLXNW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$15.45MFY 2023 Net Income: -$5.11M2023FY 2024 Net Income: -$16.52M2024FY 2025 Net Income: -$11.91M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $7.14M $5.82M $3.71M
Total Operating Expenses $11.63M $12.57M $4.68M
Operating Income -$11.63M -$12.57M -$4.68M
EBITDA -$11.62M -$12.55M -$4.64M
Interest Income $155K $28K $153K
Income Before Tax -$11.91M -$16.51M -$5.08M
Income Tax Expense $3.0K $10K $32K
Net Income -$11.91M -$16.52M -$5.11M
Basic EPS $21,333.33 $940,333.33 $7,187,382,187.38
Diluted EPS $21,333.33 $940,333.33 $7,187,382,187.38
Basic Shares Outstanding 558 17 0
Diluted Shares Outstanding 558 17 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.29M $2.21M $1.37M $3.38M $2.16M $1.02M $590K $871K
Total Operating Expenses $2.68M $3.68M $2.75M $4.41M $3.29M $2.28M $1.65M $1.90M
Operating Income -$2.68M -$3.68M -$2.75M -$4.41M -$3.29M -$2.28M -$1.65M -$1.90M
EBITDA -$2.68M -$3.68M -$2.75M -$4.40M -$3.29M -$2.28M -$1.65M -$1.91M
Interest Income $18K $14K $32K $69K $39K $44K $2.0K $3.0K
Income Before Tax -$2.53M -$3.55M -$2.73M -$4.41M -$3.26M -$2.50M -$1.74M -$1.75M
Income Tax Expense -- -- -- -- $0 $3.0K -- $1.0K
Net Income -$2.53M -$3.55M -$2.73M -$4.41M -$3.26M -$2.50M -$1.74M -$1.75M
Basic EPS $13.70 $1,230.95 $2,023.81 -- $691.14 $10,283.33 $9,142.86 --
Diluted EPS $13.70 $1,230.95 $2,023.81 -- $691.14 $10,283.33 $9,142.86 --
Basic Shares Outstanding 184.9K 2.9K 1.4K -- 4.7K 243 190 --
Diluted Shares Outstanding 184.9K 2.9K 1.4K -- 4.7K 243 190 --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $5.99M $1.19M $4.59M
Cash & Short-Term Investments $5.99M $1.19M $4.59M
Other Current Assets $49K $62K $24K
Total Current Assets $6.64M $2.25M $4.98M
Property, Plant & Equipment, Net $25K $30K $49K
Total Non-Current Assets $578K $613K $277K
Total Assets $7.21M $2.86M $5.26M
Accounts Payable $787K $929K $319K
Other Current Liabilities -- $0 $200K
Total Current Liabilities $2.76M $3.52M $2.20M
Total Non-Current Liabilities $1.85M $3.33M $59K
Total Liabilities $4.61M $6.85M $2.25M
Total Debt (incl. Leases) $468K $526K $171K
Common Stock $42K $2.0K $1.0K
Retained Earnings -$55.17M -$43.25M -$26.81M
Total Stockholders' Equity $2.60M -$3.99M -$15.48M
Total Equity $2.60M -$3.99M $3.00M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.76M $2.23M $2.41M $5.99M $9.24M $3.47M $6.15M $1.19M
Cash & Short-Term Investments $4.76M $2.23M $2.41M $5.99M $9.24M $3.47M $6.15M $1.19M
Other Current Assets $102K $111K $96K $49K $47K $63K $58K $62K
Total Current Assets $6.11M $3.74M $4.07M $6.64M $11.05M $5.24M $7.72M $2.25M
Property, Plant & Equipment, Net $21K $20K $23K $25K $26K $30K $32K $30K
Total Non-Current Assets $716K $505K $537K $578K $559K $560K $586K $613K
Total Assets $6.83M $4.25M $4.60M $7.21M $11.61M $5.80M $8.31M $2.86M
Accounts Payable $1.24M $1.18M $912K $787K $946K $692K $722K $929K
Other Current Liabilities -- -- -- -- -- -- -- $0
Total Current Liabilities $3.68M $3.98M $4.06M $2.76M $2.79M $2.15M $2.40M $3.52M
Total Non-Current Liabilities $178K $226K $251K $1.85M $1.85M $3.53M $3.33M $3.33M
Total Liabilities $3.86M $4.20M $4.31M $4.61M $4.64M $5.68M $5.72M $6.85M
Total Debt (incl. Leases) $374K $425K $436K $468K $485K $508K $489K $526K
Common Stock $1.95M $160K $46K $42K $42K $8.0K $8.0K $2.0K
Retained Earnings -$63.98M -$61.45M -$57.90M -$55.17M -$50.75M -$47.49M -$44.99M -$43.25M
Total Stockholders' Equity $2.97M $44K $291K $2.60M $6.98M $120K $2.59M -$3.99M
Total Equity $2.97M $44K $291K $2.60M $6.98M $120K $2.59M -$3.99M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$11.91M -$16.52M -$5.11M
Depreciation & Amortization $14K $25K $45K
Stock-Based Compensation $134K $5.86M $130K
Change in Payables -$142K $610K $79K
Operating Cash Flow -$10.82M -$8.40M -$4.53M
Capital Expenditure -$9.0K -$22K -$12K
Free Cash Flow -$10.83M -$8.42M -$4.54M
Investing Cash Flow -$14K -$22K $573K
Financing Cash Flow $15.64M $5.10M $522K
Net Change in Cash $4.81M -$3.31M -$3.43M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.53M -$3.55M -$2.73M -$4.41M -$3.26M -$2.50M -$1.74M -$1.75M
Depreciation & Amortization $2.0K $3.0K $2.0K $3.0K $4.0K $3.0K $4.0K -$12K
Stock-Based Compensation $16K $197K $345K $38K $38K $37K $21K $0
Change in Payables $64K $268K $125K -$159K $254K -$30K -$207K $131K
Operating Cash Flow -$2.11M -$2.92M -$3.65M -$3.02M -$2.84M -$2.51M -$2.45M -$2.93M
Capital Expenditure -$42K $0 $0 -$2.0K $0 -$1.0K -$6.0K $0
Free Cash Flow -$2.15M -$2.92M -$3.65M -$3.02M -$2.84M -$2.51M -$2.46M -$2.93M
Investing Cash Flow -$42K -$1.0K $0 -$7.0K $0 -$1.0K -$6.0K $0
Common Stock Issued $1.90M $1.99M $83K -- $0 $0 $0 --
Financing Cash Flow $4.70M $2.74M $83K -$221K $8.62M -$195K $7.43M --
Net Change in Cash $2.55M -$186K -$3.56M -$3.24M $5.78M -$2.70M $4.97M -$742K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -457.6% -- --
Return on Assets (ROA) -165.1% -577.0% -97.2%
Current Ratio 2.41x 0.64x 2.27x
Quick Ratio 2.17x 0.34x 2.09x
Debt to Equity 0.18x -- --
EPS Growth (YoY) -97.7% -100.0% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -445.7% -31722.7% -4436.4% -457.6% -132.5% -14870.8% -650.9% --
Return on Assets (ROA) -193.8% -328.7% -280.5% -165.1% -79.6% -307.8% -202.6% -577.0%
Current Ratio 1.66x 0.94x 1.00x 2.41x 3.97x 2.44x 3.22x 0.64x
Quick Ratio 1.29x 0.56x 0.59x 2.17x 3.32x 1.61x 2.57x 0.34x
Debt to Equity 0.13x 9.66x 1.50x 0.18x 0.07x 4.23x 0.19x --
EPS Growth (YoY) -98.0% -88.0% -77.9% -- -100.0% -100.0% -100.0% --
Source: SEC EDGAR CompanyFacts (CIK 0002022416) · from June 30, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:16 UTC · Open in terminal